Osteonecrosis
54
5
9
23
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.0%
7 terminated out of 54 trials
76.7%
-9.9% vs benchmark
11%
6 trials in Phase 3/4
30%
7 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (54)
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Emerging Indications for Hyperbaric Oxygen Treatment
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
TESS V3 Modular Total Shoulder System PMCF
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
Early Feasibility Study of Cartilage Defect Repair
Exactech Shoulder Post Market Clinical Follow-up Study
Sickle Cell Disease (SCD) Bone Pain Study
ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head
Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head
MOTO Post-marketing Surveillance Study
PROMIS Evaluation Study
Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement
A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty
Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip